​HemoCath Ltd. is an early-stage Canadian/US/Irish company that has developed and is now commercializing outside the United States the HemoCath Pulmonary Artery (PA) Catheter, indicated for the assessment of a patient’s hemodynamic condition through direct simultaneous CVP and PAP monitoring.

​HemoCath-guided healthcare for patients with heart failure has the potential to improve clinical outcomes and reduce hospital length of stay. HemoCath PA Catheter is less invasive due to its 4F catheter size and easier-to-use by design.

Executive Team & Co-Founders 

​Eric Caron
Chief Executive Officer
Eric brings 25 years of extensive operational experience in product design, development, and commercialization in both medical device and high technology industries. He is committed to build and lead an organization dedicated to the design, development, and commercialization of  medical devices, which enhance the skill of clinicians and deliver superior clinical outcomes to patients within the value-based medicine environment. Eric is a serial entrepreneur who has founded multiple start-ups and businesses in his career. Eric is the inventor of a number of patents covering the intellectual property of novel medical devices. He holds a BS in electrical/software engineering, and an MBA.

​Christopher Glover, MD, FRCPC
Chief Medical Officer
Dr. Christopher Glover is Interventional Cardiologist and Director of Cardiac Catheterization at the University of Ottawa Heart Institute. Dr. Glover is also Associate Professor and Director of Education and Clinical Services in the division of cardiology at the University of Ottawa. His expertise in valve diseases and transcatheter valve replacements was achieved overtime through 15+ years as an interventional cardiologist. ​Dr. Glover is part of several committees including: Examination Board for Cardiology and the Specialty Committee in Cardiology, Royal College of Physicians and Surgeons of Canada (FRCPC) . ​

​Des Regan
Chief Technology Officer
Des is an expert in engineering development of novel medical devices, with an impressive track record over the past 30 years. He founded and lead a number of startup companies developing medical devices in Ireland.  AP Design was founded by Des in 2005 and acquired by a division of Phillips Medisize a Molex company in 2013. Des has been Director of Product Development since 2003 with established companies such as Nordson Medical, Phillips Medisize and Medtronic. He is named inventor on 23 patents and several patent applications in the medical field. He holds a BS and MS in mechanical engineering.

​Michael Nagy
Chief Regulatory Officer
​Michael has 33 years of experience leading advanced engineering teams for Olympus, Goodrich, Adva Optical, the American and European space programs, and several successful start-ups, where he has commercialized breakthrough microsensor, microelectronics, and micro-optics based products for aerospace, consumer, industrial, telecommunications, and biomedical applications. He co-founded Endotronix, Inc and led development of its wireless implantable sensor system from inception through PMA trials.  Mr. Nagy holds bachelor’s and master’s degrees in electrical engineering from the University of Detroit and Case Western Reserve University. He is an inventor on 27 US patents.

Locations

Canada

101 Charles St. E, unit 2104, Toronto, ON M4Y 0A9, Canada

USA

750 Warrenville Road, suite 303, Lisle, IL  60532-0902, USA

Ireland

Unit 109, NUIG Business Innovation Centre, Upper Newcastle, Galway, H91 AX62​, Ireland

Memorial

Memorial tribute to Luc Bilodeau, MD

MEMORIAL tribute